A novel full-human CD22-CAR T cell therapy with potent activity against CD22(low) B-ALL

Tan, Y; Cai, HD; Li, C; Deng, BP; Song, WL; Ling, ZJ; Hu, G; Yang, YK; Niu, PP; Meng, GR; Cheng, W; Xu, JL; Duan, JJ; Wang, ZL; Yu, XJ; Feng, XM; Zhou, JF; Pan, J

Pan, J (corresponding author), Beijing Boren Hosp, Boren Biotherapy Translat Lab, State Key Lab Expt Hematol, Boren Clin Translat Ctr,Dept Hematol, Beijing 100070, Peoples R China.; Feng, XM (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol & Blood Dis Hosp, Tianjin 300020, Peoples R China.; Zhou, JF (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan 43003

BLOOD CANCER JOURNAL, 2021; 11 (4):